Human Milk and Its Effect on Infant's Metabolism and Infant Gut Microbiome
MAINHEALTH
The Influence of Maternal Health on Human Breast Milk Composition With Potential Downstream Effects on Infant Metabolism and Gut Colonization
1 other identifier
observational
168
1 country
1
Brief Summary
This protocol explains the MAINHEALTH cohort. The study examine the influence of maternal health parameters on human breast milk composition and integrates milk phenotype with infant metabolism and infant gut microbial content and metabolism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedFirst Submitted
Initial submission to the registry
September 24, 2021
CompletedFirst Posted
Study publicly available on registry
November 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2028
April 29, 2026
April 1, 2026
7.8 years
September 24, 2021
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolite profile of human milk
Human milk metabolites by Nuclear Magnetic Resonance (NMR) spectroscopy. Data will be analysed as absolute concentrations of milk metabolites; how milk metabolite profiles are related to mother's blood chemistry, milk microbial profiles, milk oligosaccharides, infant urine metabolome, and infant fecal microbiomes will be explored using multivariate analyses.
Birth to 3 months
Secondary Outcomes (12)
Metabolite profile of human milk by Liquid Chromatography-Mass Spectrometry (LC-MS) analysis
Birth to 3 months
Milk proteome profile
Birth to 3 months
Milk protein post-translational modification (PTM) profile
Birth to 3 months
Milk glycome profile
Birth to 3 months
Microbial structure of human milk
Birth to 3 months
- +7 more secondary outcomes
Study Arms (3)
Maternal pre-gestational BMI 18.5<25
Maternal pre-gestational BMI 25<30
Maternal pre-gestational BMI >30
Eligibility Criteria
Residence in Aarhus area is necessary and Aarhus University Hospital has to be the place of giving birth. This is due to samples being collected by midwifes during labor and when study personnel collect samples in study participants' homes.
You may qualify if:
- Residing in Aarhus area
- Above 18 years of age
- BMI above 18.5 kg/m2
- Intention to breastfeed the first four to six months following birth
- Be able to communicate in Danish
You may not qualify if:
- Smoking
- Multiple gestation
- Suffering from the following chronic diseases that demands medical treatment: diabetes mellitus, celiac disease, inflammatory bowel disease (Chrohn's disease or ulcerosa colitis)
- Taking medicaments for irritable bowel syndrome
- Taking medicine for metabolic disorders
- Taking medicine for psychological disorders
- Have had gastric bypass surgery
- Planned caesarean section
- Received antibiotics after week 12 in their pregnancy
- Utilizing significant amount of infant formula following birth
- Infants born after gestational age 37 weeks
- Infants with a birth weight between 2500 g and 5000 g
- Inborn errors of metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- University of Copenhagencollaborator
- Arla Foodscollaborator
- Aarhus University Hospitalcollaborator
Study Sites (1)
Aarhus University
Aarhus, 8200, Denmark
Related Publications (1)
Overgaard Poulsen K, Astono J, Jakobsen RR, Uldbjerg N, Fuglsang J, Nielsen DS, Sundekilde UK. Influence of maternal body mass index on human milk composition and associations to infant metabolism and gut colonisation: MAINHEALTH - a study protocol for an observational birth cohort. BMJ Open. 2022 Nov 2;12(11):e059552. doi: 10.1136/bmjopen-2021-059552.
PMID: 36323479BACKGROUND
Biospecimen
Blood sample (mother, Gestational age (GA) week 20-24) Vaginal swap (Copan Eswab; mother at birth) Rectum swap (Copan Eswab; mother at birth) Breast milk (3, 30, 60, 90 days postpartum) Urine (infant; 30, 60, 90 days postpartum) Feces (infant; 30, 60, 90 days and 1, 2, 3, 4, and 5 years postpartum) Saliva (Copan Eswab; infant 30 days postpartum) Breast skin (Copan Eswab; mother 30 days postpartum)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ulrik K Sundekilde, PhD
University of Aarhus
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2021
First Posted
November 8, 2021
Study Start
June 1, 2019
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
April 30, 2028
Last Updated
April 29, 2026
Record last verified: 2026-04